LCM

Lynx1 Capital Management Portfolio holdings

AUM $346M
This Quarter Return
+71.69%
1 Year Return
-2.97%
3 Year Return
+1,498.67%
5 Year Return
–
10 Year Return
–
AUM
$388M
AUM Growth
+$388M
Cap. Flow
-$6.73M
Cap. Flow %
-1.73%
Top 10 Hldgs %
96.84%
Holding
17
New
2
Increased
7
Reduced
6
Closed
1

Top Buys

1
MRUS icon
Merus
MRUS
$16.8M
2
GHRS icon
GH Research
GHRS
$15.7M
3
STOK icon
Stoke Therapeutics
STOK
$9.99M
4
SLN
Silence Therapeutics
SLN
$6.28M
5
PASG icon
Passage Bio
PASG
$6.03M

Top Sells

1
ALPN
Alpine Immune Sciences, Inc. Common Stock
ALPN
$61.9M
2
AUTL
Autolus Therapeutics
AUTL
$2.99M
3
THRX
Theseus Pharmaceuticals, Inc. Common Stock
THRX
$2.84M
4
CABA icon
Cabaletta Bio
CABA
$468K
5
PVLA
Palvella Therapeutics, Inc. Common Stock
PVLA
$183K

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
ALPN
1
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
$89.3M 23.01%
2,253,183
-1,560,743
-41% -$61.9M
MRUS icon
2
Merus
MRUS
$4.98B
$68M 17.5%
1,509,007
+373,782
+33% +$16.8M
STOK icon
3
Stoke Therapeutics
STOK
$1.08B
$49.9M 12.85%
3,696,820
+739,902
+25% +$9.99M
TCRX icon
4
TScan Therapeutics
TCRX
$102M
$41.5M 10.68%
5,224,600
– –
CABA icon
5
Cabaletta Bio
CABA
$133M
$35.5M 9.15%
2,082,973
-27,428
-1% -$468K
GHRS icon
6
GH Research
GHRS
$837M
$35.3M 9.09%
3,310,563
+1,471,946
+80% +$15.7M
CCCC icon
7
C4 Therapeutics
CCCC
$185M
$29.7M 7.65%
3,634,662
+500,266
+16% +$4.09M
SLN
8
Silence Therapeutics
SLN
$227M
$11.4M 2.93%
526,642
+290,855
+123% +$6.28M
AUTL
9
Autolus Therapeutics
AUTL
$399M
$8.87M 2.28%
1,390,160
-468,249
-25% -$2.99M
PASG icon
10
Passage Bio
PASG
$22.7M
$6.54M 1.69%
4,845,871
+4,466,712
+1,178% +$6.03M
KNTE
11
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$5.27M 1.36%
1,981,106
-15,900
-0.8% -$42.3K
IBIO icon
12
iBio
IBIO
$16.1M
$2.44M 0.63%
+600,000
New +$2.44M
NKTR icon
13
Nektar Therapeutics
NKTR
$568M
$1.93M 0.5%
2,068,842
+139,644
+7% +$130K
PVLA
14
Palvella Therapeutics, Inc. Common Stock
PVLA
$599M
$1.61M 0.41%
8,779,162
-996,687
-10% -$183K
NEUP
15
Neuphoria Therapeutics Inc. Common Stock
NEUP
$21.3M
$839K 0.22%
814,467
-9,838
-1% -$10.1K
CNTA
16
Centessa Pharmaceuticals
CNTA
$2.25B
$197K 0.05%
+17,400
New +$197K
THRX
17
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
– –
-702,415
Closed -$2.84M